Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ono Pharmaceutical Co. (OPHLF : OTC)

• Company Description    Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. Number of Employees: 4,287

• Price / Volume Information    Yesterday's Closing Price: $12.20 Daily Weekly Monthly 20 Day Moving Average: 93 shares Shares Outstanding: 469.71 (millions) Market Capitalization: $5,730.44 (millions) Beta: 0.19 52 Week High: $12.75 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.87% 14.79% 12 Week 11.47% 6.84% Year To Date 27.08% 11.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8-2 Kyutaromachi 1-chome Chuo-ku - Osaka,M0 541-8564 JPN ph: 816-6263-5670 fax: 816-6263-2950 None http://www.ono-pharma.com

• General Corporate Information    Officers Akira Sagara - Chief Executive Officer; Chairman and Director Takino Toichi - Chief Operating Officer; President and Director Akihiro Tsujinaka - Executive Vice President and Director Masao Nomura - Director Akiko Okuno - Director Peer Information Ono Pharmaceutical Co. (GSAC) Ono Pharmaceutical Co. (CASI) Ono Pharmaceutical Co. (ALCD.) Ono Pharmaceutical Co. (OMNN) Ono Pharmaceutical Co. (CGPI.) Ono Pharmaceutical Co. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: J61546115 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/02/26 Share - Related Items Shares Outstanding: 469.71 Most Recent Split Date: 3.00 (5.00:1) Beta: 0.19 Market Capitalization: $5,730.44 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/02/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 17.43 PEG Ratio: - Price Ratios Price/Book: 1.07 Price/Cash Flow: 11.32 Price / Sales: 1.70 EPS Growth vs. Year Ago Period: 33.33% vs. Previous Quarter: 23.08% Sales Growth vs. Year Ago Period: 6.61% vs. Previous Quarter: -0.44% ROE 09/30/25 - 6.18 06/30/25 - 5.47 03/31/25 - 6.20 ROA 09/30/25 - 4.66 06/30/25 - 4.12 03/31/25 - 4.66 Current Ratio 09/30/25 - - 06/30/25 - 2.99 03/31/25 - 3.07 Quick Ratio 09/30/25 - - 06/30/25 - 2.44 03/31/25 - 2.56 Operating Margin 09/30/25 - 9.75 06/30/25 - 8.75 03/31/25 - 10.24 Net Margin 09/30/25 - 9.75 06/30/25 - 8.75 03/31/25 - 10.24 Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - 12.19 Book Value 09/30/25 - - 06/30/25 - 11.43 03/31/25 - 11.07 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - 2.30 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.13 03/31/25 - 0.13 Debt-to-Capital 09/30/25 - - 06/30/25 - 11.13 03/31/25 - 11.76

Powered by Zacks Investment Research ©